Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Immunophenotype

Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1

Abstract

Translocations involving 11q23 are among the most common genetic abnormalities in hematologic malignancies, occurring in approximately 5–10% of acute lymphoblastic leukemia (ALL) and 5% of acute myeloblastic leukemia (AML). In 11q23 translocations, the mixed lineage leukemia (MLL) gene on chromosome 11, band q23, is usually disrupted. The human homologue of the rat NG2 chondroitin sulfate proteoglycan molecule, as detected by the monoclonal antibody (moab) 7.1, was shown to be expressed on leukemic cells with MLL rearrangements of children with acute leukemia. We further investigated the reactivity of the moab 7.1 on 533 cell samples of adults (n = 215) and children (n = 318) with acute leukemias (271 AML, 217 B-lineage ALL, 37 T-lineage ALL, eight CD7+ CD56+ myeloid/natural killer cell precursor acute leukemias) by flow cytometry. In AML, 38 samples were positive for moab 7.1 (‘20%-cut-off-level’). These moab 7.1-positive AML cases revealed a myelomonocytic-differentiated immunophenotype with coexpression of the NK cell marker CD56 in 33 of 38 cases. Two of eight cell samples of the recently described CD7+ CD56+ myeloid/natural killer cell precursor acute leukemia entity reacted with moab 7.1. In ALL, 35 samples mostly of the pro-B-ALL subtype (33 pro-B-ALL, one common-ALL, one pre-B-ALL) were positive for moab 7.1. 58 (81%) of 72 samples with MLL rearrangements were positive for moab 7.1 including 28/31 with a t(4;11), 16/17 with a t(9;11), 3/5 with a t(11;19), and 2/6 with a del(11)(q23). All moab 7.1-positive ALL (n = 34) and childhood AML (n = 17) cases revealed MLL rearrangements as detected by Southern blot analysis and RT-PCR. However, 11 adults with AML, and one adult with moab 7.1-positive CD7+ CD56+myeloid/natural killer cell precursor acute leukemia were negative for MLL rearrangements as proved by Southern blot analysis. We conclude that moab 7.1 is a sensitive but not entirely specific marker for the identification of 11q23-associated AML and ALL by flow cytometry in children and adults.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Smith FO, Rauch C, Williams DE, March CJ, Arthur D, Hilden J, Lampkin BC, Buckley JD, Buckley CV, Woods WG, Dinndorf PA, Sorensen P, Kersey J, Hammond D, Bernstein ID . The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23 Blood 1996 87: 1123–1133

    CAS  PubMed  Google Scholar 

  2. Behm FG, Smith FO, Raimondi SC, Pui CH, Bernstein ID . Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhoodacute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements Blood 1996 87: 1134–1139

    CAS  PubMed  Google Scholar 

  3. Hilden JM, Smith FO, Frestedt JL, McGlennen R, Howells WB, Sorensen PH, Arthur DC, Woods WG, Buckley J, Bernstein ID, Kersey JH . MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia Blood 1997 89: 3801–3805

    CAS  PubMed  Google Scholar 

  4. Ludwig WD, Ritter J, Knapp W, Gadner H, Thiel E, Riehm H . Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia Leukemia 1989 3: 431–439

    CAS  PubMed  Google Scholar 

  5. Rubnitz JE, Behm FG, Downing JR . 11q23 rearrangements in acute leukemia Leukemia 1996 10: 74–82

    CAS  PubMed  Google Scholar 

  6. Behm FG, Raimondi SC, Frestedt JL, Liu Q, Crist WM, Downing JR, Rivera GK, Kersey JH, Pui CH . Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age Blood 1996 87: 2870–2877

    CAS  PubMed  Google Scholar 

  7. Pui CH, Ribeiro RC, Campana D, Raimondi SC, Hancock ML, Behm FG, Sandlund JT, Rivera GK, Evans WE, Crist WM, Krance R . Prognostic factors in the acute lymphoid and myeloid leukemias of infants Leukemia 1996 10: 952–956

    CAS  PubMed  Google Scholar 

  8. Secker Walker LM . General Report on the European Union Concerted Action Workshop on 11q23, London, UK, May 1997 Leukemia 1998 12: 776–778

    Article  CAS  Google Scholar 

  9. Dördelmann M, Reiter A, Borkhardt A, Ludwig WD, Götz N, Viehmann S, Gadner H, Riehm H, Schrappe M . Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia Blood 1999 94: 1209–1217

    PubMed  Google Scholar 

  10. Look AT . Oncogenic transcription factors in the human acute leukemias Science 1997 278: 1059–1064

    Article  CAS  Google Scholar 

  11. Margolis RU, Margolis RK . Chondroitin sulfate proteoglycans as mediators of axon growth and pathfinding Cell Tissue Res 1997 290: 343–348

    Article  CAS  Google Scholar 

  12. Levine JM, Nishiyama A . The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells Perspect Dev Neurobiol 1996 3: 245–259

    CAS  Google Scholar 

  13. Nishiyama A, Dahlin KJ, Stallcup WB . The expression of NG2 proteoglycan in the developing rat limb Development 1991 111: 933–944

    CAS  PubMed  Google Scholar 

  14. Suzuki R, Yamamoto K, Seto M, Kagami Y, Ogura M, Yatabe Y, Suchi T, Kodera Y, Morishima Y, Takahashi T, Saito H, Ueda R, Nakamura S . CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity Blood 1997 90: 2417–2428

    CAS  PubMed  Google Scholar 

  15. Béné MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB . Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL) Leukemia 1995 9: 1783–1786

    PubMed  Google Scholar 

  16. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposals for the classification of the acute leukaemias. French–American–British (FAB) co-operative group Br J Haematol 1976 33: 451–458

    Article  CAS  Google Scholar 

  17. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French–American–British Cooperative Group Ann Intern Med 1985 103: 620–625

    Article  CAS  Google Scholar 

  18. Ludwig WD, Bartram CR, Ritter J, Raghavachar A, Hiddemann W, Heil G, Harbott J, Seibt Jung H, Teichmann JV, Riehm H . Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis Blood 1988 71: 1518–1528

    CAS  PubMed  Google Scholar 

  19. Ludwig WD, Rieder H, Bartram CR, Heinze B, Schwartz S, Gassmann W, Löffler H, Hossfeld D, Heil G, Handt S, Heyll A, Diedrich H, Fischer K, Weiss A, Volkers B, Aydemir U, Fonatsch C, Gökbuget N, Thiel E, Hoelzer D . Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89 Blood 1998 92: 1898–1909

    CAS  PubMed  Google Scholar 

  20. Béné MC, Bernier M, Casasnovas RO, Castoldi G, Knapp W, Lanza F, Ludwig WD, Matutes E, Orfao A, Sperling C, van't Veer MB . The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL) Blood 1998 92: 596–599

    PubMed  Google Scholar 

  21. Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 1988 16: 1215

    Article  CAS  Google Scholar 

  22. Repp R, Borkhardt A, Haupt E, Kreuder J, Brettreich S, Hammermann J, Nishida K, Harbott J, Lampert F . Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis Leukemia 1995 9: 210–215

    CAS  PubMed  Google Scholar 

  23. Mitelman F . ISCN (1995). Guidelines for Cancer Cytogenetics. Supplement to: An International System for Human Cytogenetic Nomenclature Karger:Basel, 1995

  24. Yu BD, Hess JL, Horning SE, Brown GA, Korsmeyer SJ . Altered Hox expression and segmental identity in Mll-mutant mice Nature 1995 378: 505–508

    Article  CAS  Google Scholar 

  25. Lawrence HJ, Largman C . Homeobox genes in normal hematopoiesis and leukemia Blood 1992 80: 2445–2453

    CAS  PubMed  Google Scholar 

  26. Joh T, Hosokawa Y, Suzuki R, Takahashi T, Seto M . Establishment of an inducible expression system of chimeric MLL-LTG9 protein and inhibition of Hox a7, Hox b7 and Hox c9 expression by MLL-LTG9 in 32Dc13 cells Oncogene 1999 18: 1125–1130

    Article  CAS  Google Scholar 

  27. Magli MC, Largman C, Lawrence HJ . Effects of HOX homeobox genes in blood cell differentiation J Cell Physiol 1997 173: 168–177

    Article  CAS  Google Scholar 

  28. Jones FS, Prediger EA, Bittner DA, De Robertis EM, Edelman GM . Cell adhesion molecules as targets for Hox genes: neural cell adhesion molecule promoter activity is modulated by cotransfection with Hox-2.5 and -2.4 Proc Natl Acad Sci USA 1992 89: 2086–2090

    Article  CAS  Google Scholar 

  29. Jones FS, Holst BD, Minowa O, De Robertis EM, Edelman GM . Binding and transcriptional activation of the promoter for the neural cell adhesion molecule by HoxC6 (Hox-3.3) Proc Natl Acad Sci USA 1993 90: 6557–6561

    Article  CAS  Google Scholar 

  30. Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, Bell S, McKenzie AN, King G, Rabbitts TH . An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes Cell 1996 85: 853–861

    Article  CAS  Google Scholar 

  31. Mielcarek M, Sperling C, Schrappe M, Meyer U, Riehm H, Ludwig WD . Expression of intercellular adhesion molecule 1 (ICAM-1) in childhood acute lymphoblastic leukaemia: correlation with clinical features and outcome Br J Haematol 1997 96: 301–307

    Article  CAS  Google Scholar 

  32. Burg MA, Grako KA, Stallcup WB . Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells J Cell Physiol 1998 177: 299–312

    Article  CAS  Google Scholar 

  33. Creutzig U, Harbott J, Sperling C, Ritter J, Zimmermann M, Löffler H, Riehm H, Schellong G, Ludwig WD . Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87 Blood 1995 86: 3097–3108

    CAS  PubMed  Google Scholar 

  34. Baer MR, Stewart CC, Lawrence D, Arthur DC, Mrozek K, Strout MP, Davey FR, Schiffer CA, Bloomfield CD . Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry Leukemia 1998 12: 317–325

    Article  CAS  Google Scholar 

  35. Seymour JF, Pierce SA, Kantarjian HM, Keating MJ, Estey EH . Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56) Leukemia 1994 8: 823–826

    CAS  PubMed  Google Scholar 

  36. Hurwitz CA, Raimondi SC, Head D, Krance R, Mirro J Jr, Kalwinsky DK, Ayers GD, Behm FG . Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children Blood 1992 80: 3182–3188

    CAS  PubMed  Google Scholar 

  37. Friedlander DR, Milev P, Karthikeyan L, Margolis RK, Margolis RU, Grumet M . The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth J Cell Biol 1994 125: 669–680

    Article  CAS  Google Scholar 

  38. Baer MR, Stewart CC, Lawrence D, Arthur DC, Byrd JC, Davey FR, Schiffer CA, Bloomfield CD . Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22) Blood 1997 90: 1643–1648

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank M Martin, K Liebezeit and K Ganzel for their excellent technical assistance and Dr A Schönberger (Beckman Coulter) for kindly providing the moab 7.1 for our investigations. The cell samples included in this study were sent from various hospitals in Germany participating in the ongoing ALL-BFM (coordinators: M Schrappe and H Riehm, Hannover), GMALL (coordinator: D Hoelzer, Frankfurt), AML-BFM (coordinator: U Creutzig, Hannover) and AML-CG (coordinators: T Büchner, Münster; W Hiddemann, München; B Wörmann, Braunschweig; W Berdel, Münster) trials. We thank the coordinators of the above studies for their continuous support as well as all clinicians providing cell samples for our investigations. This work was supported by grants of the ‘Deutsche José Carreras Leukämie Stiftung’ (JCLS 1998/NAT-3 to CW) and the ‘Deutsche Leukämie-Forschungshilfe’ (DLFH-98.04 to VR).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wuchter, C., Harbott, J., Schoch, C. et al. Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1. Leukemia 14, 1232–1238 (2000). https://doi.org/10.1038/sj.leu.2401840

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401840

Keywords

This article is cited by

Search

Quick links